Abstract
An estimated 17.6 per 100,000 new cases of childhood cancer are diagnosed each year in the United States. The major subtypes of childhood cancer include leukemia, central nervous system tumors, lymphoma, neuroblastoma, rhabdomyosarcoma, osteosarcoma, Ewing sarcoma, Wilms tumor, Germ cell tumors, and other rare tumors. Despite improvements in the diagnosis and treatment of these tumors over the last 30 years, subsets of children still have poor outcomes and many others have significant morbidity. Dysregulation of apoptotic pathways has been shown to contribute to tumor formation as well as resistance to therapy in both pediatric and adult malignancies. Survivin, the smallest member of the inhibitor of apoptosis protein (IAP) family, is highly expressed in diverse cancers and correlates with decreased patient survival. Here, we review the current literature on Survivin expression in pediatric cancer, its relationship to clinical outcome and potential therapeutic options to target this protein in pediatric cancer.
Keywords: Apoptosis, IAP, pediatric cancer, surviving, CNS tumor, caspase, Lymphoma, dysregulation, cytoplasm, Nucleus
Current Pediatric Reviews
Title: Inhibition of Apoptosis in Pediatric Cancer by Survivin
Volume: 7 Issue: 4
Author(s): Ayman Samkari and Rachel A. Altura
Affiliation:
Keywords: Apoptosis, IAP, pediatric cancer, surviving, CNS tumor, caspase, Lymphoma, dysregulation, cytoplasm, Nucleus
Abstract: An estimated 17.6 per 100,000 new cases of childhood cancer are diagnosed each year in the United States. The major subtypes of childhood cancer include leukemia, central nervous system tumors, lymphoma, neuroblastoma, rhabdomyosarcoma, osteosarcoma, Ewing sarcoma, Wilms tumor, Germ cell tumors, and other rare tumors. Despite improvements in the diagnosis and treatment of these tumors over the last 30 years, subsets of children still have poor outcomes and many others have significant morbidity. Dysregulation of apoptotic pathways has been shown to contribute to tumor formation as well as resistance to therapy in both pediatric and adult malignancies. Survivin, the smallest member of the inhibitor of apoptosis protein (IAP) family, is highly expressed in diverse cancers and correlates with decreased patient survival. Here, we review the current literature on Survivin expression in pediatric cancer, its relationship to clinical outcome and potential therapeutic options to target this protein in pediatric cancer.
Export Options
About this article
Cite this article as:
Samkari Ayman and A. Altura Rachel, Inhibition of Apoptosis in Pediatric Cancer by Survivin, Current Pediatric Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339611796892283
DOI https://dx.doi.org/10.2174/157339611796892283 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Molecular Link Between Diabetes and Breast Cancer: Therapeutic Potential of Repurposing Incretin-based Therapies for Breast Cancer
Current Cancer Drug Targets The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection
Current Medicinal Chemistry The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology The Impact of Gynecological Cancer on Reproductive Issues and Pregnancy:Psychological Implications
Current Women`s Health Reviews How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes?
Current Women`s Health Reviews Oral HPV Infection: Current Strategies for Prevention and Therapy
Current Pharmaceutical Design Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews Improving Health Care for Children with Chronic Conditions: Toward a “Wholistic” Approach
Current Pediatric Reviews Glioma Stem Cell Maintenance: The Role of the Microenvironment
Current Pharmaceutical Design In Silico Analysis of Amino Acid Sequences in Relation to Specificity and Physiochemical Properties of Mesophilic and Thermophilic Antileukemic L-Asparaginases
Current Biotechnology Mining Sarcomas by Proteomics Approaches: Ewing Sarcoma on the Spotlight
Recent Patents on Biotechnology Human Carbonyl Reductases
Current Drug Metabolism Small Molecule Inhibitors of the XIAP Protein-Protein Interaction
Current Topics in Medicinal Chemistry Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia
Current Cancer Therapy Reviews Posaconazole: A New Antifungal Weapon
Reviews on Recent Clinical Trials Neuroblastoma and Stem Cell Therapy: An Updated Review
CNS & Neurological Disorders - Drug Targets Genetics of Congenital Heart Disease
Current Cardiology Reviews Manufacturing and Regulatory Strategies for Clinical AAV2-hRPE65
Current Gene Therapy Different Treatment Strategies for Pediatric Brain Tumors
Current Pediatric Reviews Treatment of Chronic Hepatitis B in Children
Recent Patents on Anti-Infective Drug Discovery